Cellectis (CLLS) Cash & Current Investments (2014 - 2026)

Cellectis' Cash & Current Investments history runs 13 years deep, the most recent figure standing at $185.7 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 28.4% year-over-year to $185.7 million; the TTM figure through Mar 2026 stood at $185.7 million (down 28.4% YoY), while the FY2025 annual figure was $208.7 million, down 19.84% from the prior year.
• Cash & Current Investments was $185.7 million for Q1 2026 at Cellectis, down from $208.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $272.8 million in Q2 2024 to a low of $93.2 million in Q3 2023.
• Historically, Cash & Current Investments has averaged $187.8 million across 5 years, with a median of $198.1 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Cash & Current Investments tumbled 55.05% in 2023, then jumped 189.25% in 2024.
• A 5-year view of Cash & Current Investments shows it stood at $101.1 million in 2022, then surged by 89.58% to $191.7 million in 2023, then jumped by 35.78% to $260.3 million in 2024, then fell by 19.84% to $208.7 million in 2025, then decreased by 11.02% to $185.7 million in 2026.
• The last three Cash & Current Investments figures came in at $185.7 million (Q1 2026), $208.7 million (Q4 2025), and $192.2 million (Q3 2025), per Business Quant data.